Caricamento...
Nanotherapeutics for multiple myeloma
Multiple myeloma (MM) is an age-related haematological malignancy with an estimated 30,000 new cases and 13,000 deaths per year. A disease of antibody-secreting malignant plasma B-cells that grow primarily in the bone marrow (BM), MM causes debilitating fractures, anaemia, renal failure, and hyperca...
Salvato in:
| Pubblicato in: | Wiley Interdiscip Rev Nanomed Nanobiotechnol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6185771/ https://ncbi.nlm.nih.gov/pubmed/29701006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.1526 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|